Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > The role of osteopontin in tumor progression and metastasis in breast cancer
Publication

Publications

The role of osteopontin in tumor progression and metastasis in breast cancer

Title
The role of osteopontin in tumor progression and metastasis in breast cancer
Type
Another Publication in an International Scientific Journal
Year
2007
Authors
Rodrigues, LR
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. View Authenticus page Without ORCID
Fernando Schmitt
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Paulsson, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Lindmark Mansson, H
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 16
Pages: 1087-1097
ISSN: 1055-9965
Other information
Authenticus ID: P-004-9JH
Abstract (EN): The use of cancer biomarkers to anticipate the outlines of disease has been an emerging issue, especially as cancer treatment has made such positive steps in the last few years. Progress in the development of consistent malignancy markers is imminent because advances in genomics and bioinformatics have allowed the examination of immense amounts of data. Osteopontin is a phosphorylated glycoprotein secreted by activated macrophages, leukocytes, and activated T lymphocytes, and is present in extracellular fluids, at sites of inflammation, and in the extracellular matrix of mineralized tissues. Several physiologic roles have been attributed to osteopontin, i.e., in inflammation and immune function, in mineralized tissues, in vascular tissue, and in kidney. Osteopontin interacts with a variety of cell surface receptors, including several integrins and CD44. Binding of osteopontin to these cell surface receptors stimulates cell adhesion, migration, and specific signaling functions. Overexpression of osteopontin has been found in a variety of cancers, including breast cancer, lung cancer, colorectal cancer, stomach cancer, ovarian cancer, and melanoma. Moreover, osteopontin is present in elevated levels in the blood and plasma of some patients with metastatic cancers. Therefore, suppression of the action of osteopontin may confer significant therapeutic activity, and several strategies for bringing about this suppression have been identified. This review looks at the recent advances in understanding the possible mechanisms by which osteopontin may contribute functionally to malignancy, particularly in breast cancer. Furthermore, the measurement of osteopontin in the blood or tumors of patients with cancer, as a way of providing valuable prognostic information, will be discussed based on emerging clinical data.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 11
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition (2006)
Another Publication in an International Scientific Journal
Agudo, A; Sala, N; Pera, G; Capella, G; Berenguer, A; Garcia, N; Palli, D; Boeing, H; Del Giudice, G; Saieva, C; Carneiro F; Berrino, F; Sacerdote, C; Tumino, R; Panico, S; Berglund, G; Siman, H; Stenling, R; Hallmans, G; Martinez, C...(mais 27 authors)
Vitamins B2 and B6 and Genetic Polymorphisms Related to One-Carbon Metabolism as Risk Factors for Gastric Adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (2010)
Article in International Scientific Journal
Eussen, SJPM; Vollset, SE; Hustad, S; Midttun, O; Meyer, K; Fredriksen, A; Ueland, PM; Jenab, M; Slimani, N; Ferrari, P; Agudo, A; Sala, N; Capella, G; Del Giudice, G; Palli, D; Boeing, H; Weikert, C; Bueno de Mesquita, HB; Buechner, FL; Carneiro F...(mais 28 authors)
Tumour necrosis factor extended haplotypes and risk for development of gastric carcinoma. (2008)
Article in International Scientific Journal
Canedo P; Durães C; Pereira F; Regalo G; Lunet N; Barros H; Carneiro F; Seruca R; Rocha J; Machado JC
Tumor necrosis factor alpha extended haplotypes and risk of gastric carcinoma (2008)
Article in International Scientific Journal
Paulo Canedo; Cecilia Duraes; Fabio Pereira; Goncalo Regalo; Nuno Lunet; Henrique Barros; Fatima Carneiro; Raquel Seruca; Jorge Rocha; Jose C Machado
The association of gastric cancer risk with plasma folate, cobalamin, and Methylenetetrahydrofolate reductase polymorphisms in the European prospective investigation into cancer and nutrition (2007)
Article in International Scientific Journal
Vollset, SE; Igland, J; Jenab, M; Fredriksen, A; Meyer, K; Eussen, S; Gjessing, HK; Ueland, PM; Pera, G; Sala, N; Agudo, A; Capella, G; Del Giudice, G; Palli, D; Boeing, H; Weikert, C; Bueno de Mesquita, HB; Carneiro F; Pala, V; Vineis, P...(mais 29 authors)

See all (16)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-10 at 08:15:48 | Privacy Policy | Personal Data Protection Policy | Whistleblowing